Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$19.1K Buy
53
+1
+2% +$342 ﹤0.01% 370
2026
Q1
$18.4K Buy
52
+13
+33% +$4.63K ﹤0.01% 379
2025
Q4
$12.7K Sell
39
-26
-40% -$8.25K ﹤0.01% 421
2025
Q3
$18.4K Hold
65
﹤0.01% 336
2025
Q2
$18.1K Buy
65
+39
+150% +$11K ﹤0.01% 334
2025
Q1
$8.16K Buy
+26
New +$7.68K ﹤0.01% 330
2024
Q2
Sell
-25
Closed -$7.11K 441
2024
Q1
$7.11K Buy
+25
New +$7.32K ﹤0.01% 308
2023
Q3
Sell
-4
Closed -$955 412
2023
Q2
$955 Sell
4
-28
-88% -$6.5K ﹤0.01% 388
2023
Q1
$7.85K Hold
32
﹤0.01% 284
2022
Q4
$8.51K Buy
32
+28
+700% +$7.51K ﹤0.01% 260
2022
Q3
$1K Buy
+4
New +$970 ﹤0.01% 332
2022
Q1
Sell
-4
Closed -$1K 111
2021
Q4
$1K Hold
4
﹤0.01% 358
2021
Q3
$1K Hold
4
﹤0.01% 345
2021
Q2
$1K Hold
4
﹤0.01% 330
2021
Q1
$1K Buy
+4
New +$954 ﹤0.01% 301

Other funds holding AMGN

TD Capital Management's AMGN Position: Q2 2026 in Review

TD Capital Management increased its Amgen (AMGN) stake by 1.9% in Q2 2026, buying an estimated $342 and bringing the position to 53 shares worth $19.1K. The position accounts for ﹤0.01% of the portfolio, ranked #370.

TD Capital Management first reported a position in AMGN in Q1 2021 and has held it in 15 quarters since. 3,158 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • TD Capital Management held 53 shares of Amgen worth $19.1K as of Q2 2026.
  • TD Capital Management bought 1 Amgen share in Q2 2026, an estimated $342.
  • Amgen made up ﹤0.01% of TD Capital Management's portfolio in Q2 2026, its #370 holding.
  • TD Capital Management first reported a position in Amgen in Q1 2021 and has held it in 15 quarters since.
  • 3,158 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on TD Capital Management's 13F filing for Q2 2026, filed 6 Aug 2026.